Brain energy metabolism and emerging metabolic treatments for early intervention in psychotic disorders 

Virginie-Anne Chouinard, MD

Converging evidence implicates brain and body metabolic dysregulation in early bipolar and psychotic disorders, involving energetic and mitochondrial mechanisms. Recent data point to the potential for new metabolic treatments in early intervention for psychosis. The lecture will present the current evidence for emerging metabolic therapeutics and ongoing clinical trials aimed at improving brain and metabolic health in early bipolar and psychotic disorders.

Virginie-Anne Chouinard, MD, is the Associate Director of the McLean Center for Metabolic Psychiatry, a staff psychiatrist and director of research at McLean OnTrack, a program for first episode psychosis at McLean Hospital, and Assistant Professor in Psychiatry at Harvard Medical School. Her clinical and research interests include early psychosis recovery and metabolic health in bipolar disorder and schizophrenia spectrum disorders. Dr. Chouinard conducts research to understand the roles of insulin resistance and energy metabolism in psychotic disorders and high-risk populations. Her research includes the investigation of treatments targeting energy metabolism to improve mood, psychosis, and cognition in bipolar disorder and schizophrenia spectrum disorders.

Link to Zoom: https://us02web.zoom.us/meeting/register/IKQPj9k7Tkm_GXhRVAkPJQ